Portfolio company
Avicenna Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops a machine learning platform to optimise small molecule drug discovery and lead-to-candidate processes for biotechnology and pharmaceutical organisations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
Anagenex
This company develops a machine learning and biochemistry platform to identify and optimise small molecule drug candidates for pharmaceutical and biotechnology organisations.
Valence Discovery
This company provides a machine learning platform for molecular design and lead optimisation to pharmaceutical and biotechnology firms.
Inductive Bio
This company provides a machine learning platform for compound optimization and ADMET prediction to biopharma and drug discovery organisations.
DeepMirror
This company develops an artificial intelligence platform for medicinal chemists at biotechnology and pharmaceutical firms to design and optimise drug molecules.
AI-DRIVEN CHEMISTRY
This company provides a machine learning platform to help pharmaceutical and chemical organisations accelerate research and development by optimizing experiments using small datasets.
DeepMirror AI
This company provides a drug design platform that uses machine learning to help medicinal chemists identify and optimise molecules for biopharmaceutical research.
Aqemia
This company develops a drug discovery platform using physics-based algorithms and artificial intelligence for pharmaceutical and biotechnology organisations.
